AC Immune

About:

AC Immune is a biopharmaceutical company focused on neurodegenerative diseases with three product candidates in clinical trials

Website: http://acimmune.com

Top Investors: Biotechnology Value Fund, Redmile Group, Avidity Partners, dievini Hopp Biotech Holding, StemPoint Capital

Description:

AC Immune is a clinical stage Swiss-based biopharmaceutical company focused on neurodegenerative diseases with three product candidates in clinical trials. The Company designs, discovers and develops therapeutic and diagnostic products intended to prevent and modify diseases caused by misfolding proteins. AC Immune's two proprietary technology platforms create antibodies, small molecules and vaccines to address a broad spectrum of neurodegenerative indications